Picture of Mesa Laboratories logo

MLAB — Mesa Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Mesa Laboratories Inc reports results for the quarter ended in December - Earnings Summary

* Mesa Laboratories Inc  MLAB.OQ  reported a quarterly
adjusted
loss of 39 cents​​ per share for the quarter ended in December.
The mean expectation of three analysts for the quarter was
for earnings of 42 cents per share.
    * Revenue rose 60.1% to $54.70 million from a year ago; 
analysts
expected $44.47 million. 
    * Mesa Laboratories Inc's reported EPS for the quarter was a
loss
of 39 cents​.
    * The mean earnings estimate of analysts had risen by
about 2.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Mesa Laboratories Inc shares had fallen by 14.8% this
quarter.
    * The company reported a quarterly loss of $2.06 million.
    * Wall Street's median 12-month price target for Mesa
Laboratories
Inc is $320.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated February 3 at 03:43 p.m.
 ​All figures in US dollars unless otherwise stated

Recent news on Mesa Laboratories

See all news